Moreover, classically activated macrophages play pivotal roles in IBD, and PIM1 inhibitors can reduce the proinflammatory response in IBD by inhibiting the hyperactivation of macrophages (62). The gene discussed is PIM1; the disease is inflammatory bowel disease.